$1.18 Billion is the total value of Opti Capital Management, LP's 49 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | BIGCOMMERCE HLDGS INCnote 0.250%10/0 | $0 | – | -4,000,000 | -100.0% | -0.25% | – | |
| Exit | UNITY SOFTWARE INCnote 11/1 | $0 | – | -6,000,000 | -100.0% | -0.38% | – | |
| Exit | MERCADOLIBRE INCnote 2.000% 8/1 | $0 | – | -2,500,000 | -100.0% | -0.61% | – | |
| Exit | HESKA CORPnote 3.750% 9/1 | $0 | – | -6,616,000 | -100.0% | -0.70% | – | |
| Exit | DROPBOX INCnote 3/0 | $0 | – | -10,850,000 | -100.0% | -0.79% | – | |
| Exit | CHEGG INCnote 0.125% 3/1 | $0 | – | -13,250,000 | -100.0% | -0.95% | – | |
| Exit | INFINERA CORPnote 2.125% 9/0 | $0 | – | -13,185,000 | -100.0% | -1.10% | – | |
| Exit | OAK STR HEALTH INCnote 3/1 | $0 | – | -14,000,000 | -100.0% | -1.12% | – | |
| Exit | AIR TRANS SVCS GROUP INCnote 1.125%10/1 | $0 | – | -15,341,000 | -100.0% | -1.18% | – | |
| Exit | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $0 | – | -8,907,000 | -100.0% | -1.40% | – | |
| Exit | CONFLUENT INCnote 1/1 | $0 | – | -31,675,000 | -100.0% | -2.03% | – | |
| Exit | RAPID7 INCnote 2.250% 5/0 | $0 | – | -25,484,000 | -100.0% | -2.13% | – | |
| Exit | PEGASYSTEMS INCnote 0.750% 3/0 | $0 | – | -35,730,000 | -100.0% | -2.60% | – | |
| Exit | NEW RELIC INCnote 0.500% 5/0 | $0 | – | -33,750,000 | -100.0% | -2.72% | – | |
| Exit | NUVASIVE INCnote 1.000% 6/0 | $0 | – | -35,410,000 | -100.0% | -2.84% | – | |
| Exit | IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $0 | – | -42,313,000 | -100.0% | -3.17% | – | |
| Exit | SUPERNUS PHARMACEUTICALSnote 0.625% 4/0 | $0 | – | -46,902,000 | -100.0% | -3.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SUPERNUS PHARMACEUTICALS INC | 14 | Q1 2023 | 6.9% |
| NEW RELIC INC | 14 | Q1 2023 | 7.6% |
| 8X8 INC NEW | 13 | Q3 2023 | 7.4% |
| MANDIANT INC | 12 | Q1 2022 | 9.9% |
| NUTANIX INC | 12 | Q4 2022 | 7.3% |
| OPKO HEALTH INC | 12 | Q3 2023 | 2.1% |
| INSIGHT ENTERPRISES INC | 10 | Q3 2023 | 5.6% |
| ALTERYX INC | 10 | Q3 2023 | 4.6% |
| IONIS PHARMACEUTICALS INC | 10 | Q1 2023 | 3.6% |
| MODEL N INC | 10 | Q3 2023 | 1.7% |
View Opti Capital Management, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Opti Capital Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.